Skip to main navigation menu Skip to main content Skip to site footer

Granulomatosis with polyangiitis with varying clinical manifestations and response. Report of two cases

Granulomatosis con poliangeitis con manifestaciones y respuesta clínica diferentes. Reporte de dos casos




Section
Reporte de caso

How to Cite
López Yepes LA, Urrutia Brán AL. Granulomatosis with polyangiitis with varying clinical manifestations and response. Report of two cases.
rev. colomb. neumol. [Internet]. 2025 Jul. 30 [cited 2025 Aug. 6];37(2). Disponible en: https://doi.org/10.30789/rcneumologia.v37.n2.2025.992

Dimensions
PlumX
license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.


Luis Alejandro López Yepes,

Neumólogo del Hospital de Referencia Nacional de Enfermedades Respiratorias (HRNER), Hospital El Pilar y clínica privada. Ciudad Guatemala, Guatemala


Ana Lucia Urrutia Brán,

Médico nutrióloga, MSc en epidemiología y estadística


Polyangiitis with granulomatosis, previously known as Wegener's granulomatosis, is a necrotizing vasculitis of small and medium-sized vessels characterized by the formation of necrotizing granulomas that primarily affect the upper respiratory tract, lungs, and kidneys. Clinically, it presents with symptoms such as chronic sinusitis, hemoptysis, dyspnea, rapidly progressive glomerulonephritis, and systemic manifestations such as fever, weight loss, and asthenia. Diagnosis is based on detecting anti-neutrophil cytoplasmic antibodies (ANCA) type PR3 and histopathological studies. Treatment includes immunosuppressants, such as corticosteroids and cyclophosphamide or rituximab, to induce remission.

Two clinical cases with diagnoses of polyangiitis with granulomatosis are reported. One was a 58-year-old man with orbital involvement, saddle nose, recurrent epistaxis, chronic rhinosinusitis, and bilateral pulmonary cavitary involvement. A second case is a 44-year-old man with chronic rhinosinusitis, recurrent epistaxis, hearing loss, and bilateral tracheobronchial stenosis and chondritis. Both cases have been positive for C-ANCA; the first involved a lung biopsy that revealed necrotizing vasculitis, and the second involved a positive skin biopsy for necrotizing vasculitis. In both cases, induction treatment started with an excellent response and is currently being maintained.


Article visits 34 | PDF visits 0


Downloads

Download data is not yet available.
  1. Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editores. Síndromes vaculiticos. En: Harrison Principios de Medicina Interna. 20a. Edición. México, D.F: McGraw-Hill Interamericana; 2018. p. 2578-81. ISBN: 978-1-4562-6310-2
  2. León-Ortiz AG, Guáman-Crespo JO, Sánchez-Zúñiga MJ, Carrillo-Esper R, León-Ortiz AG, Guáman-Crespo JO, et al. Granulomatosis con poliangítis, granulomatosis de Wegener. Medicina interna de México [Internet]. 2017 [citado el 24 de mayo de 2024];33(3):421-6. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_abstract&pid=S0186-48662017000300421&lng=es&nrm=iso&tlng=es
  3. Brown KK, Frankel SK, Cool CD. 60 - Pulmonary Vasculitis. En: Broaddus VC, Mason RJ, Ernst JD, King TE, Lazarus SC, Murray JF, et al. editores. Murray and Nadel’s Textbook of Respiratory Medicine (Sixth Edition). Philadelphia: W.B. Saunders; 2016. p. 1066-1080.e9. doi: https://doi.org/10.1016/B978-1-4557-3383-5.00060-9
  4. Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis. Annals of the Rheumatic Diseases. 2022;81(3):309-14. doi: https://doi.org/10.1136/annrheumdis-2021-221794
  5. Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Arthritis & Rheumatology. 2021;73(8):1366-83. doi: https://doi.org/10.1002/art.41773
  6. Hoyos Patiño S. Granulomatosis con poliangeítis: actualización y conceptos claves. Revista Cubana de Reumatología [Internet]. 2016 [citado el 16 de mayo de 2024];18(1):36-44. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S1817-59962016000100007&lng=es&nrm=iso&tlng=es
  7. Cantillo J de J, Díaz JEA, Andrade RE. Granulomatosis de Wegener. Una enfermedad de varias caras. Acta Médica Colombiana [Internet]. 2007 [citado el 26 de mayo de 2024];32(3):136-44. Disponible en: https://www.redalyc.org/articulo.oa?id=163114146021
  8. Álvarez Herrera T, Santana Matheu G, Placeres Hernández JF. Enfermedad de Wegener o granulomatosis con poliangeítis. Presentación de un caso. Revista Médica Electrónica [Internet]. junio de 2018 [citado el 16 de mayo de 2024];40(3):790-7. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S1684-18242018000300020&lng=es&nrm=iso&tlng=es
Sistema OJS 3.4.0.7 - Metabiblioteca |